PL354414A1 - Zastosowanie L-karnityny i jej pochodnych alkanoilowych jako środki osmotyczne w roztworach do użytku medycznego - Google Patents

Zastosowanie L-karnityny i jej pochodnych alkanoilowych jako środki osmotyczne w roztworach do użytku medycznego

Info

Publication number
PL354414A1
PL354414A1 PL99354414A PL35441499A PL354414A1 PL 354414 A1 PL354414 A1 PL 354414A1 PL 99354414 A PL99354414 A PL 99354414A PL 35441499 A PL35441499 A PL 35441499A PL 354414 A1 PL354414 A1 PL 354414A1
Authority
PL
Poland
Prior art keywords
carnitine
solutions
osmotic agents
alkanoyl derivatives
medical use
Prior art date
Application number
PL99354414A
Other languages
English (en)
Other versions
PL213131B1 (pl
Inventor
Arduino Arduini
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority to PL354414A priority Critical patent/PL213131B1/pl
Publication of PL354414A1 publication Critical patent/PL354414A1/pl
Publication of PL213131B1 publication Critical patent/PL213131B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL354414A 1999-10-11 1999-10-11 Zastosowanie roztworu srodka osmotycznego i roztwór do dializy otrzewnowej PL213131B1 (pl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL354414A PL213131B1 (pl) 1999-10-11 1999-10-11 Zastosowanie roztworu srodka osmotycznego i roztwór do dializy otrzewnowej

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL354414A PL213131B1 (pl) 1999-10-11 1999-10-11 Zastosowanie roztworu srodka osmotycznego i roztwór do dializy otrzewnowej
PCT/IT1999/000317 WO2001026649A1 (en) 1999-10-11 1999-10-11 Use of l-carnitine and its alkanoyl derivatives as osmotic agents in solutions for medical use

Publications (2)

Publication Number Publication Date
PL354414A1 true PL354414A1 (pl) 2004-01-12
PL213131B1 PL213131B1 (pl) 2013-01-31

Family

ID=11333127

Family Applications (1)

Application Number Title Priority Date Filing Date
PL354414A PL213131B1 (pl) 1999-10-11 1999-10-11 Zastosowanie roztworu srodka osmotycznego i roztwór do dializy otrzewnowej

Country Status (20)

Country Link
US (2) US6822002B1 (pl)
EP (1) EP1220670B1 (pl)
JP (1) JP4638106B2 (pl)
KR (1) KR100642731B1 (pl)
AT (1) ATE336243T1 (pl)
AU (1) AU1073400A (pl)
CA (1) CA2386826C (pl)
CY (1) CY1106203T1 (pl)
CZ (1) CZ303870B6 (pl)
DE (1) DE69932860T2 (pl)
DK (1) DK1220670T3 (pl)
ES (1) ES2270620T3 (pl)
HK (1) HK1046090B (pl)
HU (1) HUP0203441A3 (pl)
MX (1) MXPA02003635A (pl)
PL (1) PL213131B1 (pl)
PT (1) PT1220670E (pl)
SI (1) SI1220670T1 (pl)
SK (1) SK288072B6 (pl)
WO (1) WO2001026649A1 (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770148B1 (en) 1998-12-04 2004-08-03 Baxter International Inc. Peritoneal dialysis solution containing modified icodextrins
ITRM20010337A1 (it) * 2001-06-14 2002-12-16 Sigma Tau Ind Farmaceuti Soluzione per la conservazione e perfuzione di organi in attesa che vengano trapiantati.
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
US7053059B2 (en) 2003-07-25 2006-05-30 Baxter International Inc. Dialysis solutions with reduced levels of glucose degradation products
ITRM20040346A1 (it) 2004-07-13 2004-10-13 Sigma Tau Ind Farmaceuti Uso della l-carnitina per il trattamento di patologie cardiovascolari.
JP2006075195A (ja) * 2004-09-07 2006-03-23 Jms Co Ltd Ｌカルニチン含有腹膜透析液
TWI388318B (zh) * 2005-03-10 2013-03-11 西格瑪 陶製藥廠 具有改良之生物相容性的含有肉毒鹼之腹膜透析溶液
US20070087975A1 (en) * 2005-10-17 2007-04-19 Sigma-Tau Industrie Farmaceutiche Riunite Spa Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients
US8876753B2 (en) 2006-01-30 2014-11-04 The Regents Of The University Of California Peritoneal dialysis methods and apparatus
CN101374558B (zh) * 2006-01-30 2013-06-12 加利福尼亚大学董事会 腹膜透析方法和装置
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
ES2396650B2 (es) * 2011-07-21 2013-07-16 Universidad Complutense De Madrid Uso de una composición en la elaboración de una solución de diálisis para el tratamiento de las enfermedades cerebrovasculares mediante diálisis peritoneal.
TWI454287B (zh) * 2012-11-21 2014-10-01 Taipei Veteran General Hospital 治療纖維化之透析液
US9539411B2 (en) 2013-03-13 2017-01-10 W. L. Gore & Associates, Inc. Deconstructable endoluminal devices and related systems and methods
CN103330715B (zh) * 2013-07-01 2015-09-02 华仁药业股份有限公司 一种抗腹膜纤维化的腹膜透析液
CN103463081B (zh) * 2013-09-27 2015-10-21 华仁药业股份有限公司 腹膜透析液
DE102015014699A1 (de) * 2015-11-13 2017-05-18 Fresenius Medical Care Deutschland Gmbh Dialyselösung mit wenigstens einem Osmotikum
EP3912656A1 (en) * 2020-05-19 2021-11-24 CoreQuest Sagl Peritoneal dialysis solution
EP4029507A1 (en) 2021-01-19 2022-07-20 Iperboreal Pharma Srl Peritoneal dialysis solution for hypertensive subjects

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1156741B (it) * 1978-05-15 1987-02-04 Sigma Tau Ind Farmaceuti Applicazione terapeutica della carnitina e di alcuni derivati acilati della carnitina nell'emodialisi
IT1120033B (it) * 1979-10-05 1986-03-19 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente-carnitina adatta per l'alimentazione parenterale
CH664374A5 (de) * 1985-02-27 1988-02-29 Lonza Ag Verfahren zur herstellung von l-carnitin auf mikrobiologischem weg.
JPH04320145A (ja) * 1991-04-19 1992-11-10 Ricoh Co Ltd ファクシミリ装置
IT1261695B (it) * 1993-06-02 1996-05-29 Sigma Tau Ind Farmaceuti Impiego di l-carnitina e alcanoil l-carnitine nella conservazione del sangue per trasfusioni e soluzioni stabilizzatrici che le contengono.
IT1283137B1 (it) 1996-07-09 1998-04-07 Bieffe Medital Spa Agenti osmotici alternativi e relative soluzioni per dialisi peritoneale
JPH1094598A (ja) 1996-07-31 1998-04-14 Baxter Internatl Inc 腹膜透析液
US5973004A (en) * 1997-04-04 1999-10-26 Howard; James R. L-carnitine, acetyl-L-carnitine, and pantothenic acid or ubiquinone, combined for prevention and treatment of syndromes related to ineffective energy metabolism
US6482585B2 (en) * 1997-04-16 2002-11-19 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Storage and maintenance of blood products including red blood cells and platelets
GB9714218D0 (en) 1997-07-04 1997-09-10 Allied Therapeutics Ltd Peritoneal dialysis fluid
JPH1149671A (ja) 1997-08-06 1999-02-23 Baxter Internatl Inc 腹膜透析液
CA2299346A1 (en) * 1997-08-07 1999-02-18 Ajay Gupta Dialysis solutions containing water soluble vitamins and nutrients
JPH1171273A (ja) 1997-08-29 1999-03-16 Terumo Corp 腹膜透析液
JPH1171286A (ja) 1997-08-29 1999-03-16 Terumo Corp 腹膜透析液
US6440449B1 (en) * 1998-01-15 2002-08-27 Edward Hirschberg Methods of infusing phytochemicals, nutraceuticals, and other compositions into food products

Also Published As

Publication number Publication date
ES2270620T3 (es) 2007-04-01
DK1220670T3 (da) 2006-12-18
SK4432002A3 (en) 2002-08-06
PL213131B1 (pl) 2013-01-31
CA2386826C (en) 2010-04-20
CZ20021063A3 (cs) 2002-08-14
HK1046090B (en) 2007-06-29
US6822002B1 (en) 2004-11-23
MXPA02003635A (es) 2002-10-23
JP2003511413A (ja) 2003-03-25
WO2001026649A1 (en) 2001-04-19
CA2386826A1 (en) 2001-04-19
US20050085542A1 (en) 2005-04-21
CY1106203T1 (el) 2011-06-08
DE69932860D1 (de) 2006-09-28
ATE336243T1 (de) 2006-09-15
EP1220670A1 (en) 2002-07-10
DE69932860T2 (de) 2007-08-30
EP1220670B1 (en) 2006-08-16
US7932291B2 (en) 2011-04-26
HUP0203441A3 (en) 2004-01-28
KR100642731B1 (ko) 2006-11-03
HUP0203441A2 (hu) 2003-03-28
HK1046090A1 (en) 2002-12-27
PT1220670E (pt) 2006-10-31
KR20020038809A (ko) 2002-05-23
CZ303870B6 (cs) 2013-06-05
JP4638106B2 (ja) 2011-02-23
SI1220670T1 (sl) 2006-12-31
SK288072B6 (sk) 2013-05-03
AU1073400A (en) 2001-04-23

Similar Documents

Publication Publication Date Title
SI1220670T1 (sl) Uporaba L-karnitina in njegovih alkanoil derivatov kot ozmotsko sredstvo za medicinske namene
BR9508554A (pt) Preparação farmaceuticamente estável de oxaliplatina
PL325825A1 (en) Microemulsion for use as a carrier for administering active compounds
HUP0105148A3 (en) Telmisartan polymorph, method for producing same and its use in the preparation of a medicament
CA2352561A1 (en) Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy
HRP20010655B1 (en) Pyridopyranoazepine derivatives, preparation and therapeutic use
ZA200108004B (en) Echinocandin/carbohydrate complexes.
WO2001028544A3 (en) Dialysis solution including polyglycol osmotic agent
MXPA02010839A (es) Solucion medica de carbohidratos y estabilizante de sulfito en un recipiente de compartimentos multiples y usos de los mismos.
WO2000008007A3 (de) Cyclopentabenzofuran-derivate und ihre verwendung
ES2183417T3 (es) Concentrado para solucion medica y su utilizacion.
AR036321A1 (es) Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia.
EE04264B1 (et) Naatriumkloriidi kasutamine aine valmistamiseks kamptotetsiini derivaatide manustamisest tingitud gastrointestinaalsete kõrvaltoimete vähendamiseks
PL346165A1 (en) Biphenylsulfonyl-substituted imidazole derivatives, their preparation process, their use as a drug or diagnostic agent and drug containing them
CA2376033A1 (en) Use of l-carnitine and its alkanoyl derivatives for the preparation of a medicament useful for the treatment of patients suffering from diabetic and/or dysmetabolic nephropathy
HUP0201810A3 (en) Sootepenseone and its derivatives, their preparation and use as medicament
AU5280799A (en) Imidazole derivatives with biphenylsulfonyl substitution, method for preparing them and their use as a drug or diagnostic agent
WO2000064421A3 (en) Use of n-acetylcysteine for the preparation of a medicament suitable for the intravenous administration to prevent oxidative stress in dialysed patients
AU6846300A (en) Use of cyamemazine for cold turkey benzodiazepine treatment
PL350413A1 (en) Pharmaceutical effervescent formulation containing metamizol
TW200714279A (en) Carniting-containing peritoneal dialysis solution having improved biocompatibility
BR0316059A (pt) Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise
WO2002030446A3 (en) Reduction or prevention of post-surgical adhesion formation with fibrinogen
UA92310C2 (ru) Композиция, которая включает натеглинид, сахар и микрокристаллическую целлюлозу
AU2001266119A1 (en) Pharmaceutical composition in liquid form for oral administration of an active principle, with unpleasant, in particular bitter, taste

Legal Events

Date Code Title Description
RECP Rectifications of patent specification